Extracellular vesicles mediate mesenchymal stromal cell-dependent regulation of B cell PI3K-AKT signaling pathway and actin cytoskeleton A Adamo, J Brandi, S Caligola, P Delfino, R Bazzoni, R Carusone, ... Frontiers in immunology 10, 446, 2019 | 82 | 2019 |
The role of notch and wnt signaling in MSC communication in normal and leukemic bone marrow niche P Takam Kamga, R Bazzoni, G Dal Collo, A Cassaro, I Tanasi, ... Frontiers in cell and developmental biology 8, 599276, 2021 | 52 | 2021 |
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease G Dal Collo, A Adamo, A Gatti, E Tamellini, R Bazzoni, P Takam Kamga, ... Stem Cells 38 (5), 698-711, 2020 | 44 | 2020 |
Role of mesenchymal stromal cell-derived extracellular vesicles in tumour microenvironment A Adamo, G Dal Collo, R Bazzoni, M Krampera Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1871 (1), 192-198, 2019 | 40 | 2019 |
Inhibition of notch signaling enhances chemosensitivity in B-cell precursor acute lymphoblastic leukemia P Takam Kamga, G Dal Collo, M Midolo, A Adamo, P Delfino, A Mercuri, ... Cancer Research 79 (3), 639-649, 2019 | 37 | 2019 |
Notch signaling molecules as prognostic biomarkers for acute myeloid leukemia P Takam Kamga, GD Collo, F Resci, R Bazzoni, A Mercuri, FM Quaglia, ... Cancers 11 (12), 1958, 2019 | 31 | 2019 |
Small molecule inhibitors of microenvironmental Wnt/β-catenin signaling enhance the chemosensitivity of acute myeloid leukemia P Takam Kamga, G Dal Collo, A Cassaro, R Bazzoni, P Delfino, A Adamo, ... Cancers 12 (9), 2696, 2020 | 15 | 2020 |
Characterization of a new B-ALL cell line with constitutional defect of the Notch signaling pathway PT Kamga, G Dal Collo, G Bassi, M Midolo, M Delledonne, M Chilosi, ... Oncotarget 9 (26), 18341, 2018 | 10 | 2018 |
The miR-200c/141-ZEB2-TGFb axis is aberrant in human T-cell prolymphocytic leukemia SJ Erkeland, CJ Stavast, J Schilperoord-Vermeulen, G Dal Collo, ... haematologica 107 (1), 143, 2022 | 9 | 2022 |
Targeting the endothelin-1 receptors curtails tumor growth and angiogenesis in multiple myeloma A Russignan, G Dal Collo, A Bagnato, N Tamassia, M Bugatti, M Belleri, ... Frontiers in Oncology 10, 600025, 2021 | 9 | 2021 |
Prognostic impact of notch signaling in acute myeloid leukemia (AML) PT Kamga, F Resci, G Dal Collo, A Adamo, R Bazzoni, A Mercuri, ... Blood 132, 5242, 2018 | 5 | 2018 |
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential A Adamo, J Brandi, R Carusone, S Caligola, D Cecconi, R Giugno, ... Cytotherapy 20 (5), 22-22, 2018 | 2 | 2018 |
Role of Wnt/β-catenin signalling in acute myeloid leukemia (AML) cell response to chemotherapy PT Kamga, A Cassaro, G Dal Collo, A Adamo, A Gatti, R Carusone, ... Blood 128 (22), 2753, 2016 | 2 | 2016 |
Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy G Dal Collo, P Takam Kamga Cancers 15 (18), 4503, 2023 | 1 | 2023 |
Inhibition of GSK-3 signalling enhances sensitivity of non-promyelocitic acute myeloid leukemia (AML) cell to chemotherapy PT Kamga, G Dal Collo, A Cassaro, A Adamo, A Gatti, R Carusone, ... Blood 128 (22), 1582, 2016 | 1 | 2016 |
Novel Anti-CD117 Antibodies for Rapid and Efficient Hematopoietic Stem Cell Depletion and Safe Bone Marrow Conditioning G Dal Collo, A van Hoven-Beijen, Y He, YM Muller, Y Wang, J Zhao, ... Blood 140 (Supplement 1), 4496-4497, 2022 | | 2022 |
THE PIVOTAL ROLE OF NOTCH SIGNALING IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) CHEMOSENSITIVITY G Dal Collo | | 2020 |
ROLE OF WNT/beta-CATENIN-GSK3 SIGNALING PATHWAY IN NON-PROMYELOCYTIC ACUTE MYELOID LEUKEMIA CELLS RESPONSE TO CHEMOTHERAPY THROUGH MICROENVIRONMENT PROTECTION G Dal Collo, PT Kamga, R Bazzoni, A Adamo, M Bonifacio, M Krampera HAEMATOLOGICA 103, S102-S103, 2018 | | 2018 |
TARGETING OF NOTCH SIGNALING IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) DRUG RESPONSE G Dal Collo, PT Kamga, M Midolo, A Adamo, P Delfino, A Mercuri, ... HAEMATOLOGICA 103, S57-S57, 2018 | | 2018 |
Mescenchymal stromal cells (hBM-MSCs) protect AML cells from drug treatment through Wnt/β-catenin signalling PT Kamga, G Dal Collo, R Bazzoni, A Adamo, R Carusone, M Bonifacio, ... Cytotherapy 20 (5), S52, 2018 | | 2018 |